The global market for Laboratory
Balances and Scales is projected to reach US$1.5 billion by 2025, driven by the
increased demand for laboratory services in healthcare, academics, life
sciences, pharmaceutical, food, and chemical industries. The market is also
driven by the stringent guidelines, regulations and recommendations for
laboratory analysis such as stringent contractual laboratory testing agreements
and arrangements. Growing safety standards in food and pharmaceutical sectors
will continue to shift the emphasis towards analytical quality, thereby driving
demand for laboratory balances and scales. The rapid growth of pharmaceutical
and biotechnology sectors and increased funding support for academia R&D
activities, the resulting increase in laboratories performing quality control
of medicines will present significant opportunities for growth. Technology
innovations will also fuel growth, especially against the backdrop where the
need to replace old and obsolete lab balances with advanced technology-based
instruments remains strong. Key trends in this regard driving adoption rates include
refreshing innovations in advanced micro, semi-micro, analytical and precision
balances; and launch of lab balances and scales with touchscreen digital
displays and ergonomic designs. Drug development and manufacturing will emerge
as key growth drivers in the pharmaceutical end-use industries. In drug
manufacturing, precision weighing of compounds and substances is vital for
quality and safety of medicines. In drug discovery, on the other hand, accurate
weighing in toxicology tests marks the difference between drug success and
failure. Few of the factors driving increased investments in pharma R&D
thereby setting the stage for growth in the market include growing population,
aging population and increasing healthcare burden; increased access to and
demand for healthcare services; increased per capita spending on medicines
worldwide; growing demand for effective drugs and therapies; wave of impending
patent expiries and the ensuing need for companies to invest in new drug
development to prevent freefall of revenues; and increasing focus on improving
pharma R&D efficiency. Read More…
The Global Market for Big Data Technologies and Services is Projected to Reach $60 Billion by 2022
GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Big Data market. The global market for Big Data Technologies and Services is projected to reach $60 billion by 2022 , driven by soaring digital data volumes in organizations and the resulting need to turn this data into valuable insights for enhancing operational efficiency, tapping new opportunities and gaining competitive edge. Defined as a natural result of mankind’s obsession with information technology and digitalization, “Big Data” refers to extremely large sets of structured, semi-structured and unstructured data of different types, including text, audio or video, generated from diverse data sources that has the potential to be mined for required information. While data supply associated with big data ecosystem has always been large and voluminous in most organizations, the ability to use these large datasets and convert them into meaningf
Comments
Post a Comment